Jeffrey A. Robl

4.5k citations

61 papers · 1.9k indexed · 1 hit paper · h-index 23

Organic Chemistry top 5%
Biochemistry top 5%
Molecular Biology top 10%
- Chemical Synthesis and Analysis 14
- Protein Hydrolysis and Bioactive Peptides 6
- Peroxisome Proliferator-Activated Receptors 4
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension 6
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
Oncology
- Peptidase Inhibition and Analysis 14
Surgery
- Lipoproteins and Cardiovascular Health 4
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 4

Co-authors: Richard Sulsky Rex A. Parker Ligaya M. Simpkins Cem Z. Görgün Keita Kono Gökhan S. Hotamışlıgil Masato Furuhashi Eric Vaillancourt
Cited by: Organic Chemistry Biochemistry Molecular Biology
Journals: Bioorganic & Medicinal Chemistry Letters (27 papers)Tetrahedron Letters (7 papers)Journal of Medicinal Chemistry (7 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Jeffrey A. Robl

59 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Jeffrey A. Robl

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Robl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Robl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Robl more than expected).

Fields of papers citing papers by Jeffrey A. Robl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Robl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Robl. The network helps show where Jeffrey A. Robl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeffrey A. Robl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey A. Robl Line = papers co-authored together Jeffrey A. Robl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists Bioorganic & Medicinal Chemistry Letters ·Xiang‐Yang Ye,淳吉永,Ying Wang,Karen A. Rossi,X. Li,Alexandre Denizot,Larisa Sereda,Atsu Apedo,Jeffrey A. Robl,Keith J. Miller,John Krupinski,Dean A. Wacker	2014	18
2	Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) Bioorganic & Medicinal Chemistry Letters ·Xiang‐Yang Ye,David Yoon,You-Jeong Hwang,Akbar Nayeem,Rajasree Golla,Ramakrishna Seethala,Mengmeng Wang,Timothy W. Harper,Bogdan Sleczka,Atsu Apedo,Yixin Li,Bin He,Mark Kirby,David A. Gordon,Jeffrey A. Robl	2013	14
3	Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists Bioorganic & Medicinal Chemistry Letters ·John M. Fevig,R. Nandakumar,Karen A. Rossi,Keith J. Miller,Ginger Wu,เลิศพร ภาระสกุล,SEDA KURT,X. Li,Ge Zhang,Ma Aránzazu Sánchez García,Mary Jane Cullen,Kenneth W. Rohrbach,一弥西澤,Jinping Gan,Mary Ann Pelleymounter,Jeffrey A. Robl	2012	10
4	Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) Bioorganic & Medicinal Chemistry Letters ·Xiang‐Yang Ye,Stephanie Chen,Akbar Nayeem,Rajasree Golla,Ramakrishna Seethala,Mengmeng Wang,Timothy W. Harper,Bogdan Sleczka,Yixin Li,Bin He,Mark Kirby,David A. Gordon,Jeffrey A. Robl	2011	11
5	Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase Bioorganic & Medicinal Chemistry Letters ·Khehyong Ngu,David S. Weinstein,Wen Liu,Charles M. Langevine,Donald W. Combs,Shaobin Zhuang,Xing Chen,Cort S. Madsen,Timothy W. Harper,Saleem Ahmad,Jeffrey A. Robl	2011	30
6	Prediction of In Vivo Enantiomeric Compositions by Modeling In Vitro Metabolic Profiles Journal of Pharmaceutical Sciences ·Mengmeng Wang,Qi Wang,Hong Cai,Bogdan Sleczka,Celia D’Arienzo,Jonathan L. Josephs,Xiang‐Yang Ye,Jeffrey A. Robl,David Gordon,David Rodrigues,Timothy W. Harper	2010	1
7	Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents Bioorganic & Medicinal Chemistry Letters ·Saleem Ahmad,Khehyong Ngu,Keith J. Miller,Ginger Wu,เลิศพร ภาระสกุล,X. Li,Ge Zhang,Maria Elisa Favarin,Ma Aránzazu Sánchez García,Mary Jane Cullen,Kenneth W. Rohrbach,Michael A. Thomas,SEDA KURT,一弥西澤,Jinping Gan,Rangaraj Narayanan,Mary Ann Pelleymounter,Jeffrey A. Robl	2009	13
8	Tetrazole based amides as growth hormone secretagogues Bioorganic & Medicinal Chemistry Letters ·James J. Li,(unknown),Haixia Wang,Jun Li,L. Marseglia,Maulina Kartika,Andrés S. Hernández,Scott A. Biller,Jeffrey A. Robl,Joseph A. Tino,G. J. Vendura,Ramakrishna Seethala,Paul G. Sleph,Mujing Yan,Gary J. Grover,Neil Flynn,Brian J. Murphy,David Gordon	2008	9
9	(d)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues Bioorganic & Medicinal Chemistry Letters ·Jun Li,Stephanie Chen,Brian J. Murphy,Neil Flynn,Ramakrishna Seethala,G. J. Vendura,Mujing Yan,Paul G. Sleph,A Walczynska,W. Griffith Humphreys,William R. Ewing,Jeffrey A. Robl,David Gordon,Joseph A. Tino	2008	11
10	Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues Bioorganic & Medicinal Chemistry Letters ·Andrés S. Hernández,Maulina Kartika,G. J. Vendura,Mujing Yan,Ramakrishna Seethala,Paul G. Sleph,Gary J. Grover,Kenneth E.J. Dickinson,Min Jung Ki,Timothy W. Harper,W. Griffith Humphreys,Daniel Angelo Longhi,Neil Flynn,Brian J. Murphy,David A. Gordon,Scott A. Biller,Jeffrey A. Robl,Joseph A. Tino	2008	3
11	Discovery, synthesis, and structure–activity studies of tetrazole based growth hormone secretagogues Bioorganic & Medicinal Chemistry Letters ·Andrés S. Hernández,Peter T. W. Cheng,Carina Karlsson,Maulina Kartika,R.J. George,Gary J. Grover,G. J. Vendura,Ramakrishna Seethala,Mark A. Smith,Kenneth E.J. Dickinson,Min Jung Ki,Daniel Angelo Longhi,Neil Flynn,Brian J. Murphy,David A. Gordon,Scott A. Biller,Jeffrey A. Robl,Joseph A. Tino	2007	22
12	Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2breakdown → Nature ·Masato Furuhashi,Gürol Tuncman,Cem Z. Görgün,Liza Makowski,Gen‐ichi Atsumi,Eric Vaillancourt,Keita Kono,Vladimir R. Babaev,Sergio Fazio,MacRae F. Linton,Richard Sulsky,Jeffrey A. Robl,Rex A. Parker,Gökhan S. Hotamışlıgil	2007	599
13	Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Doree Sitkoff,Jing Zhang,Wei Han,Zilun Hu,Philip D. Stein,Ying Wang,Lawrence J. Kennedy,Stephen P. O’Connor,Esther Ngozi Ohihoin,Eddie C.‐K. Liu,Henrik Lundström,Patrick Y. S. Lam,Jeffrey A. Robl,John E. Macor,Karnail S. Atwal,Robert Zahler	2007	9
14	Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP) Bioorganic & Medicinal Chemistry Letters ·Richard Sulsky,David R. Magnin,Yanting Huang,Ligaya M. Simpkins,Prakash C. Taunk,Manorama M. Patel,Yeheng Zhu,Terry R. Stouch,Donna Bassolino‐Klimas,Rex A. Parker,Thomas Harrity,Robert H. Stoffel,David S. Taylor,Thomas Lavoie,Kevin Kish,Bruce L. Jacobson,S. Sheriff,Leonard P. Adam,William R. Ewing,Jeffrey A. Robl	2006	126
15	Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors Bioorganic & Medicinal Chemistry Letters ·Guohua Zhao,Prakash C. Taunk,David R. Magnin,Ligaya M. Simpkins,Jeffrey A. Robl,Aiying Wang,James G. Robertson,Jovita Marcinkeviciene,Doree Sitkoff,Rex A. Parker,Mark Kirby,Lawrence G. Hamann	2005	19
16	5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP Bioorganic & Medicinal Chemistry Letters ·Richard Sulsky,Jeffrey A. Robl,Scott A. Biller,Thomas Harrity,John R. Wetterau,Fergal Connolly,Kern G. Jolibois,Lori Kunselman	2004	26
17	N-Formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Robl,Ligaya M. Simpkins,Magdi M. Asaad	2000	25
18	Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure. Journal of Pharmacology and Experimental Therapeutics ·N. C. Trippodo,Jeffrey A. Robl,Magdi M. Asaad,J. Eileen Bird,B C Panchal,Thomas Schaeffer,María Ofelia Barber Fox,Mary R. Giancarli,H.S. Cheung	1995	74
19	Phosphorus-containing inhibitors of HMG-CoA reductase. I. 4-[(2-Arylethyl)hydroxyphosphinyl]-3-hydroxybutanoic acids: a new class of cell selective inhibitors of cholesterol biosynthesis Journal of Medicinal Chemistry ·Donald S. Karanewsky,Michael C. Badia,Carl P. Ciosek,Jeffrey A. Robl,Michael J. Sofia,Ligaya M. Simpkins,Barbara DeLange,Thomas Harrity,Scott A. Biller,Eric M. Gordon	1990	42
20	Instrumentation and Separation Results of Medium Pressure Liquid Chromatography Journal of Chromatographic Science ·Jih Ru Hwu,Jeffrey A. Robl,Боднар Ю.І.	1987	7

About Jeffrey A. Robl

Jeffrey A. Robl is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (14 papers), Chemical Synthesis and Analysis (14 papers), Hormonal Regulation and Hypertension (6 papers), Protein Hydrolysis and Bioactive Peptides (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Organic Chemistry (668 citations), Biochemistry (110 citations) and Molecular Biology (1.0k citations). Jeffrey A. Robl has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Richard Sulsky, Rex A. Parker, Ligaya M. Simpkins, Cem Z. Görgün, Keita Kono, Gökhan S. Hotamışlıgil, Masato Furuhashi, Eric Vaillancourt, Gürol Tuncman and Liza Makowski. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, Journal of the American Chemical Society and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact